November 15, 2021 11:29 AM EST
News Briefing

Cas­sa­va be­ing in­ves­ti­gat­ed by un­named 'gov­ern­ment agen­cies'; Rock­et Phar­ma gives up­dat­ed da­ta on Danon dis­ease

Paul Schloesser

Associate Editor

Josh Sullivan

Max Gelman

Senior Editor

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA

TRENDING NOW

FDA picks con­tro­ver­sial doc­tor Vinay Prasad as CBER di­rec­tor, in about-face from Marks

Biotech stocks plunge and in­dus­try fig­ures left to won­der af­ter Prasad's FDA ap­point­ment

Sarep­ta’s stock plum­mets af­ter Prasad ap­point­ment, low Ele­v­idys sales

Live at 11 a.m.: What Vinay Prasad means for CBER, vac­cines, drug ap­provals and more

Trump, FDA ze­ro in on for­eign fac­to­ries to give do­mes­tic sites an edge  

sponsored

In one of the riski­est in­dus­tries — Biotech — a sure­fire way to neu­tral­ize some of that risk emerges

A service from the Financial Times